MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0111031
Medisap Pharma Private Limited
Medisap Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.56 Cr
▼ 23% YoY
Net loss · FY 2025
₹37,310
Net margin 0%
EBITDA · FY 2025
₹16.42 Lakh
EBITDA margin 2.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹30,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
20
Provident fund records
Directors on board
3
As per MCA filings
About Medisap Pharma Private Limited
Data last updated:
Medisap Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC342166. Its GSTIN is 27AANCM5898G1ZP (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹30,000. It is led by directors including Umesh Yadav and Amit Swatantra Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 38/102 Akash Ganga Shanti Nagar Chs. Ltd Shanti Nagar Sector – 8 Miraroad(E), Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.56 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹37,310 (net margin 0%) and EBITDA of ₹16.42 Lakh (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
The company has about 20 employees on its provident fund (EPFO) records.
Court records list 13 cases involving the company, including 13 filed by the company; 9 cases are pending.
Medisap Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0111031).
Company details
CIN U24290MH2020PTC342166
Registration Number 342166
Incorporation Date 18 July 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-18-0111031
Recognitions & Rankings of Medisap Pharma
Contact details
Medisap Pharma Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 38/102 Akash Ganga Shanti Nagar Chs. Ltd Shanti Nagar Sector – 8 Miraroad(E), Thane, Maharashtra, India – 401107
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medisap Pharma Private Limited, buy the company report.
Comprehensive company report
Medisap Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medisap Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Medisap Pharma Private Limited, buy the company report.
Financials of Medisap Pharma Private Limited
FY 2025 filings availableMedisap Pharma Private Limited reported revenue of ₹7.56 Cr (down 23% YoY) for FY 2025.
Revenue · FY 2025
₹7.56 Cr ▼ 23%
Net loss · FY 2025
₹37,310 margin 0%
EBITDA · FY 2025
₹16.42 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▲ 202%
3 years · compounded
▼ 9%
Revenue has declined at a compounded annual rate (CAGR) of 14% over three years, including a 23% fall in the latest year. EBITDA rose 202% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹37,310 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medisap Pharma Private Limited, buy the company report.
Board of directors of Medisap Pharma Private Limited
Medisap Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Yadav | Director | 18 Jul 2020 | 6 Years 3 Months | Current |
| Amit Swatantra Singh | Director | 18 Jul 2020 | 6 Years 3 Months | Current |
| Swaminath Shivmangal Yadav | Director | 18 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Medisap Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Malmatha Shetkari Vikas Producer Company Limited | ₹7.58 Cr (FY 2025) | -48.0% | Malegaon, Maharashtra, India | |||
| Rids Multi Management Private Limited | ₹7.58 Cr (FY 2025) | 140.0% | Kolkata, West Bengal, India | |||
| Synerggy Chemist Private Limited | ₹7.58 Cr (FY 2025) | 11.0% | Pune, Maharashtra, India | |||
| Vish Roto Casing Private Limited | ₹7.57 Cr (FY 2025) | 53.0% | Tumkur, Karnataka, India | |||
| Ferrous Tradelink Private Limited | ₹7.57 Cr (FY 2025) | 277.0% | Nagpur, Maharashtra, India | |||
| Medisap Pharma Private Limitedthis company | ₹7.56 Cr (FY 2025) | -₹37,310 | 0% | -23.0% | 20 | Thane, Maharashtra, India |
| Coffee Addict Private Limited | ₹7.55 Cr (FY 2025) | -11.0% | Chikkamagalur, Karnataka, India | |||
| Safetek Engineering Solutions Private Limited | ₹7.55 Cr (FY 2025) | -57.0% | New Delhi, Delhi, India | |||
| Mercenary Consumer Products Private Limited | ₹7.55 Cr (FY 2025) | 74.0% | Chennai, Tamil Nadu, India | |||
| Optilab Technologies Private Limited | ₹7.54 Cr (FY 2025) | 41.0% | Mumbai, Maharashtra, India | |||
| Sanjivan Health Foods Private Limited | ₹7.54 Cr (FY 2025) | 37613.0% | Ratnagiri, Maharashtra, India |
To see the full peer comparison of Medisap Pharma Private Limited, buy the company report.
Auditor
Medisap Pharma Private Limited is audited by M H Choudhary & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M H Choudhary & Company | FY 2023 | 153072W |
Shareholding
The shareholding of Medisap Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medisap Pharma Private Limited, buy the company report.
Legal cases
Medisap Pharma Private Limited has 13 court cases on record: 13 filed by Medisap Pharma. 9 cases are pending and 4 are disposed.
Total cases
13
Filed by the company
13
Pending
9
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 0 | 9 |
Cases on record (4 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Mrs. Shital Sachin Karandkar M/S Secetrum Pharma | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES W) | Filed by the company against individuals | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Mrs. Shital Sachin Karandkar M/S Secetrum Pharma | Disposed |
To see the full case history of Medisap Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medisap Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medisap Pharma Private Limited has a workforce of 20 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
-16.67%
GST
Medisap Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCM5898G1ZP | Maharashtra | Active | 04 Sep 2020 |
To see the full GST registrations and return filing status of Medisap Pharma Private Limited, buy the company report.
Recent activity
Medisap Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Amit Swatantra Singh was appointed as Director on 18 Jul 2020.
AGM
Medisap Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medisap Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Amit Swatantra Singh was appointed as Director.
Appointed
Swaminath Shivmangal Yadav was appointed as Director.
Appointed
Umesh Yadav was appointed as Director.
Incorporation
18 Jul 2020
Medisap Pharma Private Limited was registered on 18 Jul 2020 with Roc Mumbai & aged 6 years 3 months as per MCA records.
Frequently asked questions
Medisap Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2020 (6+ years old) and is registered under CIN U24290MH2020PTC342166.
Medisap Pharma has 3 current directors:
- Umesh Yadav - Director
- Amit Swatantra Singh - Director
- Swaminath Shivmangal Yadav - Director
The latest financial statements of Medisap Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Medisap Pharma is 27AANCM5898G1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medisap Pharma is U24290MH2020PTC342166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medisap Pharma has 13 court cases on record: 13 filed by the company. 9 are pending.
Medisap Pharma was incorporated on 18 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medisap Pharma by revenue are Malmatha Shetkari Vikas Producer Company Limited, Rids Multi Management Private Limited, Synerggy Chemist Private Limited, Vish Roto Casing Private Limited, Ferrous Tradelink Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Amit Swatantra Singh was appointed as Director on 18 Jul 2020. Swaminath Shivmangal Yadav was appointed as Director on 18 Jul 2020. Umesh Yadav was appointed as Director on 18 Jul 2020.
Yes, Medisap Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0111031).
The registered office of Medisap Pharma is at C – 38102 Akash Ganga Shanti Nagar Chs. Ltd Shanti Nagar Sector – 8 MiraroadE, Thane, Maharashtra, India – 401107.